Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

setrobuvir

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
  • A. Elfiky
  • Journal of biomolecular structure & dynamics
  • 2020
  • Corpus ID: 216556215
Abstract New treatment against SARS-CoV-2 now is a must. Nowadays, the world encounters a huge health crisis by the COVID-19… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2018
2018
Abstract A new Zika virus (ZIKV) outbreak started in 2015. According to the World Health Organization, 84 countries confirmed… Expand
Is this relevant?
2018
2018
BACKGROUND Viral kinetic models have proven useful in characterizing treatment effectiveness during HCV therapy with interferon… Expand
Is this relevant?
2016
2016
Setrobuvir is a direct‐acting antiviral (DAA) non‐nucleoside inhibitor of hepatitis C virus (HCV) polymerase. This study examined… Expand
Is this relevant?
2014
2014
PURPOSE New antiviral agents with activity against hepatitis C virus (HCV) are needed to optimize treatment for chronic hepatitis… Expand
  • table I
  • figure 1
  • figure 2
  • table II
  • figure 3
Is this relevant?
2012
2012
1 Hepatitis C Non-Nucleoside Polymerase and Protease Inhibitors 2 3 Authors: Micaela B. Reddy, Peter N. Morcos, Sophie Le Pogam… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2011
2011
  • Nature Reviews Drug Discovery
  • 2011
  • Corpus ID: 2665333
hepatitis C virus (HCV) infection involves treatment with ribavirin and pegylated interferon (PEG-IFN). This stimulates the… Expand
Is this relevant?